Literature DB >> 32857891

Susceptibility-Weighted 3T MRI of the Swallow Tail Sign in Multiple Sclerosis: A Case Control Study.

Claudia E Weber1, Anne Ebert1, Michael Platten1, Achim Gass1, Philipp Eisele1.   

Abstract

BACKGROUND AND
PURPOSE: The swallow tail sign describes the physiological appearance of nigrosome-1 within the substantia nigra on high-resolution transverse susceptibility-weighted imaging (SWI). Previous studies demonstrated its absence in Parkinson's disease due to increasing iron content. In multiple sclerosis (MS), increased iron accumulation can be found in the brain tissue including the substantia nigra.
METHODS: We investigated the swallow tail sign on high-resolution SWI MRI in 46 MS and 23 age- and sex-matched controls.
RESULTS: MS patients demonstrated significantly more often an abnormal swallow tail sign (28/46; 60%) compared to controls (4/23; 17%; P = .001). In MS patients, we found no correlation between an abnormal swallow tail sign and age, disease duration or Expanded Disability Status Scale scores.
CONCLUSION: The finding of an abnormal swallow tail sign in MS patients may provide an additional imaging marker even in early MS development.
© 2020 American Society of Neuroimaging.

Entities:  

Keywords:  MRI; Multiple sclerosis; SWI; swallow tail sign

Mesh:

Year:  2020        PMID: 32857891     DOI: 10.1111/jon.12775

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  2 in total

1.  Acceleration of Brain Susceptibility-Weighted Imaging with Compressed Sensitivity Encoding: A Prospective Multicenter Study.

Authors:  J Ding; Y Duan; M Wang; Y Yuan; Z Zhuo; L Gan; Q Song; B Gao; L Yang; H Liu; Y Hou; F Zheng; R Chen; J Wang; L Lin; B Zhang; G Zhang; Y Liu
Journal:  AJNR Am J Neuroradiol       Date:  2022-03-03       Impact factor: 3.825

2.  Loss of swallow tail sign on susceptibility-weighted imaging in neurosyphilis mimicking Alzheimer's disease: a case report.

Authors:  Xiao-Li Cui; Shen Liu; Yi-Ming Zhang; Hong-Dong Zhao; Jian-Quan Shi
Journal:  Acta Neurol Belg       Date:  2022-09-30       Impact factor: 2.471

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.